Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACTU Actuate Therapeutics Inc

盘后交易 12-19 17:46:36 EST

7.05

-0.07

-0.98%

盘后5.91

-1.14-16.17%

17:00 EST

最高7.81	最低7.00	成交量8.27万
今开7.30	昨收7.12	日振幅11.31%
总市值1.38亿	流通市值4,650万	总股本1,953万
成交额60.21万	换手率1.25%	流通股本659.52万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACTU","market":"US","secType":"STK","nameCN":"Actuate Therapeutics Inc","latestPrice":7.05,"timestamp":1734642000000,"preClose":7.12,"halted":0,"volume":82703,"hourTrading":{"tag":"盘后","latestPrice":5.91,"preClose":7.05,"latestTime":"17:00 EST","volume":299,"amount":2096.5500868,"timestamp":1734645609364},"delay":0,"floatShares":6595163,"shares":19531636,"eps":-7.368504,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.07,"latestTime":"12-19 17:46:36 EST","open":7.3,"high":7.805,"low":7,"amount":602116.5863554999,"amplitude":0.113062,"askPrice":7.59,"askSize":75,"bidPrice":5.9,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-7.368504,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734656400000},"adr":0,"listingDate":1723521600000,"adjPreClose":7.12,"preHourTrading":{"tag":"盘前","latestPrice":6.99,"preClose":7.12,"latestTime":"09:14 EST","volume":219,"amount":1362.0200862000002,"timestamp":1734617698415},"postHourTrading":{"tag":"盘后","latestPrice":5.91,"preClose":7.05,"latestTime":"17:00 EST","volume":299,"amount":2096.5500868,"timestamp":1734645609364},"volumeRatio":0.70986},"requestUrl":"/m/hq/s/ACTU/tweets","defaultTab":"tweets","newsList":[{"id":"2492171880","title":"Actuate Therapeutics, Inc.盘中异动 早盘股价大涨9.62%报7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492171880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492171880?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:42","pubTimestamp":1734619336,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时42分，Actuate Therapeutics, Inc.股票出现异动，股价大幅拉升9.62%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.54%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224218a1fb5bba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224218a1fb5bba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2492181008","title":"Actuate Therapeutics, Inc.股价飙升10.70% 市值涨117.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492181008?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:32","pubTimestamp":1734532334,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时32分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨10.70%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822321495ea5488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822321495ea5488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACTU"],"gpt_icon":0},{"id":"2492965393","title":"Actuate Therapeutics, Inc.盘中异动 快速上涨7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965393?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:33","pubTimestamp":1734446000,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时33分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨7.13%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223327a1f60909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223327a1f60909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2491636667","title":"澳洲财长透露央行改革新任命 市场预测2月降息可能性为62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491636667","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491636667?lang=zh_cn&edition=full","pubTime":"2024-12-16 12:05","pubTimestamp":1734321942,"startTime":"0","endTime":"0","summary":"在工党正在寻求选举前降息之际，财政部长Jim Chalmers透露了政府对澳洲联储理事会的任命。在央行的重大改组中，澳洲联储理事会将分为两个不同的委员会，分别负责利率制定和治理。这项改革将于3月1日生效。这两人将加入澳洲联储理事会现任成员CarolynHewson、IanHarper、IainRoss和AlisonWatkins的行列，后者四人已同意在利率制定委员会任职。他还表示，被任命者所具备的一系列技能，为新一届澳洲联储理事会的成功奠定了基础。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/16120546411497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"2491375272","title":"Actuate Therapeutics, Inc.盘中异动 股价大跌7.24%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491375272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491375272?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:32","pubTimestamp":1734100331,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时32分，Actuate Therapeutics, Inc.股票出现波动，股价快速下挫7.24%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223211ab758cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223211ab758cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2490893174","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨6.80%报8.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490893174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490893174?lang=zh_cn&edition=full","pubTime":"2024-12-12 01:30","pubTimestamp":1733938250,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日01时30分，Actuate Therapeutics, Inc.股票出现波动，股价急速拉升6.80%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121201305095e8ff2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121201305095e8ff2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2490042552","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042552","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490042552?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:46","pubTimestamp":1733856383,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时46分，Actuate Therapeutics, Inc.股票出现波动，股价快速拉升7.11%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1987.87%、473.53%、179.25%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.，振幅分别为154.91%、131.78%、121.49%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121102462395e8ba48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121102462395e8ba48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACTU","BK4139"],"gpt_icon":0},{"id":"2489316962","title":"Actuate Therapeutics, Inc.盘中异动 早盘急速拉升6.62%报9.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489316962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489316962?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:47","pubTimestamp":1733496425,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时47分，Actuate Therapeutics, Inc.股票出现异动，股价大幅上涨6.62%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206224705ab62ddc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206224705ab62ddc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2489953117","title":"Actuate Therapeutics, Inc.盘中异动 大幅上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489953117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489953117?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:28","pubTimestamp":1733333302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时28分，Actuate Therapeutics, Inc.股票出现波动，股价大幅拉升5.33%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205012822971ba865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205012822971ba865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2488377920","title":"Actuate Therapeutics, Inc.盘中异动 股价大跌7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488377920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488377920?lang=zh_cn&edition=full","pubTime":"2024-12-04 03:36","pubTimestamp":1733254581,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日03时36分，Actuate Therapeutics, Inc.股票出现异动，股价大幅下跌7.74%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204033621971b6afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204033621971b6afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACTU"],"gpt_icon":0},{"id":"2488603334","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488603334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488603334?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:49","pubTimestamp":1733154589,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时49分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨5.29%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202234949a266c111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202234949a266c111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2486009704","title":"Actuate Therapeutics, Inc.盘中异动 急速下跌5.90%报8.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486009704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486009704?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631466,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分，Actuate Therapeutics, Inc.股票出现异动，股价快速下挫5.90%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为13.01%、9.59%、9.52%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Bioline Rx Ltd、Fate Therapeutics, Inc.，振幅分别为10.91%、8.17%、7.85%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223106971a89e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223106971a89e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACTU"],"gpt_icon":0},{"id":"2486403181","title":"Actuate Therapeutics, Inc.盘中异动 早盘快速拉升6.12%报9.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486403181?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:49","pubTimestamp":1732549751,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时49分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨6.12%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234912abde208d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234912abde208d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2484324674","title":"Actuate Therapeutics, Inc.盘中异动 早盘急速拉升5.01%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484324674","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484324674?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:06","pubTimestamp":1731942365,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时06分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨5.01%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230605a2433b23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230605a2433b23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2483852583","title":"Actuate Therapeutics, Inc.盘中异动 下午盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483852583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483852583?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:05","pubTimestamp":1731528321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时05分，Actuate Therapeutics, Inc.股票出现波动，股价快速跳水5.43%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040522971a65e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040522971a65e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACTU","LENZ"],"gpt_icon":0},{"id":"2482732814","title":"Actuate Therapeutics, Inc.盘中异动 股价大跌5.14%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482732814?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:21","pubTimestamp":1731342089,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时21分，Actuate Therapeutics, Inc.股票出现波动，股价快速跳水5.14%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200212998e41d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200212998e41d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACTU"],"gpt_icon":0},{"id":"2482343134","title":"Actuate Therapeutics, Inc.盘中异动 下午盘快速下跌6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482343134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482343134?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:46","pubTimestamp":1731091610,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时46分，Actuate Therapeutics, Inc.股票出现异动，股价急速下挫6.97%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902465098e418ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902465098e418ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2481983368","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨5.68%报9.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983368?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:34","pubTimestamp":1730903665,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时34分，Actuate Therapeutics, Inc.股票出现异动，股价快速上涨5.68%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223425971a4c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223425971a4c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2480062589","title":"Actuate Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报8.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480062589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480062589?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730686,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Actuate Therapeutics, Inc.股票出现波动，股价快速上涨5.11%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223126971a423a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223126971a423a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2480836298","title":"Actuate Therapeutics, Inc.盘中异动 临近午盘股价大跌8.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480836298?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:53","pubTimestamp":1730476425,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时53分，Actuate Therapeutics, Inc.股票出现波动，股价大幅跳水8.00%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101235345971a3e7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101235345971a3e7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACTU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actuatetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1066},{"period":"1month","weight":-0.2054},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.11},{"period":"ytd","weight":-0.11}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actuate Therapeutics, Inc.于2015年1月16日在特拉华州注册成立，名称为Apotheca Therapeutics, Inc.，并于2015年10月1日更名为Actuate Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过抑制糖原合成酶激酶-3（GSK-3）开发治疗高影响、难以治疗的癌症的疗法。他们正在开发elraglusib（前身为9-ING-41），这是一种小分子，旨在进入癌症细胞并阻断GSK-3β酶的功能，GSK-3是复杂生物信号级联的主要调节因子，包括致癌基因介导的信号级联，导致肿瘤细胞存活、生长、迁移和侵袭。","exchange":"NASDAQ","name":"Actuate Therapeutics Inc","nameEN":"Actuate Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actuate Therapeutics Inc(ACTU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actuate Therapeutics Inc,ACTU,Actuate Therapeutics Inc股票,Actuate Therapeutics Inc股票老虎,Actuate Therapeutics Inc股票老虎国际,Actuate Therapeutics Inc行情,Actuate Therapeutics Inc股票行情,Actuate Therapeutics Inc股价,Actuate Therapeutics Inc股市,Actuate Therapeutics Inc股票价格,Actuate Therapeutics Inc股票交易,Actuate Therapeutics Inc股票购买,Actuate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actuate Therapeutics Inc(ACTU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}